Japan’s Takeda opens dengue vaccine manufacturing facility in Germany

This article was originally published here

The company will use the new manufacturing plant for formulation, fill, finish and secondary packaging of the TAK-003 tetravalent dengue vaccine candidate. Takeda started the initial construction activities

The post Japan’s Takeda opens dengue vaccine manufacturing facility in Germany appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply